GlassScriptPhysician profile
Malav Parikh
NPI 1366804940
$11,651.37
in general payments reported to CMS, 2019-2025
26 companies · $1,443 in 2025
The $1,443 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.73 · 2020: $388 · 2021: $2,974 · 2022: $5,555 · 2023: $653 · 2024: $550 · 2025: $1,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,645.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,253.58 | 2021-2022 | |
| Abbott Laboratories | $935.22 | 2021-2025 | Ultreon, Coroflow, Xience Skypoint |
| Cardiovascular Systems INC. | $928.52 | 2020-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $699.64 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $528.77 | 2021-2025 | Avvigo Guidance System |
| Abiomed | $388.67 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $295.72 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $265.13 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $259.87 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $244.12 | 2020-2021 | |
| Stryker Corporation | $222.31 | 2025 | Artix Mt, Flowtriever |
| Heartflow, INC. | $110.87 | 2022 | |
| Edwards Lifesciences Corporation | $88.96 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Astellas Pharma US INC | $84.99 | 2020 | |
| Imperative Care, INC | $83.45 | 2025 | Symphony Catheter |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $47.22 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $32.12 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $29.76 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $28.60 | 2024 | Opsumit, Uptravi |
| Teleflex LLC | $23.98 | 2025 | Manta |
| Regeneron Healthcare Solutions, INC. | $22.29 | 2019 | |
| Cardiva Medical, INC. | $17.67 | 2022 | |
| Merck Sharp & Dohme LLC | $17.12 | 2023 | Verquvo |
| Pentax of America, INC. | $16.33 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.84 | 2022 | |
| Irhythm Technologies, INC. | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malav Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.